Associations between Psychosocial and Physiological Factors and Diabetes Health Indicators in Asian and Pacific Islander Adults with Type 2 Diabetes

Por Li, Dongmei, Inouye, Jillian, Davis, Jim, Arakaki, Richard F.
Publicado em 2013

Changes in Fasting Plasma Glucose Levels with Ribavirin and Pegylated Interferon Treatment in Normal and Impaired Glucose Tolerant Patients with Chronic Hepatitis C

Por Sarasombath, Ongkarn, Suwantarat, Nuntra, Tice, Alan D, Arakaki, Richard F
Publicado em 2012

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes

Por Bergenstal, Richard M., Rosenstock, Julio, Arakaki, Richard F., Prince, Melvin J., Qu, Yongming, Sinha, Vikram P., Howey, Daniel C., Jacober, Scott J.
Publicado em 2012

Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treate...

Por Bergenstal, Richard M., Rosenstock, Julio, Arakaki, Richard F., Prince, Melvin J., Qu, Yongming, Sinha, Vikram P., Howey, Daniel C., Jacober, Scott J.
Publicado em 2013

The Association of ENPP1 K121Q with Diabetes Incidence Is Abolished by Lifestyle Modification in the Diabetes Prevention Program

Por Moore, Allan F., Jablonski, Kathleen A., Mason, Clinton C., McAteer, Jarred B., Arakaki, Richard F., Goldstein, Barry J., Kahn, Steven E., Kitabchi, Abbas E., Hanson, Robert L., Knowler, William C., Florez, Jose C.
Publicado em 2009

Effects of Genetic Variants Previously Associated with Fasting Glucose and Insulin in the Diabetes Prevention Program

Por Florez, Jose C., Jablonski, Kathleen A., McAteer, Jarred B., Franks, Paul W., Mason, Clinton C., Mather, Kieren, Horton, Edward, Goldberg, Ronald, Dabelea, Dana, Kahn, Steven E., Arakaki, Richard F., Shuldiner, Alan R., Knowler, William C.
Publicado em 2012